25 XP   0   0   10

Compumedics Ltd
Buy, Hold or Sell?

Let's analyse Compumedics together

PenkeI guess you are interested in Compumedics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Compumedics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Compumedics Ltd

I send you an email if I find something interesting about Compumedics Ltd.

Quick analysis of Compumedics (30 sec.)










What can you expect buying and holding a share of Compumedics? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.10
Expected worth in 1 year
A$-0.02
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
A$-0.12
Return On Investment
-45.2%

For what price can you sell your share?

Current Price per Share
A$0.27
Expected price per share
A$0.265 - A$0.27
How sure are you?
50%

1. Valuation of Compumedics (5 min.)




Live pricePrice per Share (EOD)

A$0.27

Intrinsic Value Per Share

A$-0.30 - A$-0.06

Total Value Per Share

A$-0.20 - A$0.04

2. Growth of Compumedics (5 min.)




Is Compumedics growing?

Current yearPrevious yearGrowGrow %
How rich?$11.7m$15.1m-$3.4m-29.0%

How much money is Compumedics making?

Current yearPrevious yearGrowGrow %
Making money-$3.9m$871.6k-$4.8m-122.2%
Net Profit Margin-14.4%3.6%--

How much money comes from the company's main activities?

3. Financial Health of Compumedics (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Compumedics? (5 min.)

Welcome investor! Compumedics's management wants to use your money to grow the business. In return you get a share of Compumedics.

What can you expect buying and holding a share of Compumedics?

First you should know what it really means to hold a share of Compumedics. And how you can make/lose money.

Speculation

The Price per Share of Compumedics is A$0.265. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Compumedics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Compumedics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.10. Based on the TTM, the Book Value Change Per Share is A$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Compumedics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-8.4%-0.02-8.4%0.001.9%0.00-1.5%0.000.6%
Usd Book Value Change Per Share-0.02-7.3%-0.02-7.3%0.012.0%0.00-1.3%0.001.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-7.3%-0.02-7.3%0.012.0%0.00-1.3%0.001.4%
Usd Price Per Share0.12-0.12-0.10-0.23-0.24-
Price to Earnings Ratio-5.21--5.21-20.24-19.89-29.30-
Price-to-Total Gains Ratio-6.02--6.02-19.12-43.93-34.55-
Price to Book Ratio1.74-1.74-1.16-2.68-3.47-
Price-to-Total Gains Ratio-6.02--6.02-19.12-43.93-34.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1702095
Number of shares5875
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (5875 shares)-112.89-20.74
Gains per Year (5875 shares)-451.55-82.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-452-4620-83-93
20-903-9140-166-176
30-1355-13660-249-259
40-1806-18180-332-342
50-2258-22700-415-425
60-2709-27220-498-508
70-3161-31740-581-591
80-3612-36260-664-674
90-4064-40780-747-757
100-4516-45300-830-840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%15.09.00.062.5%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%16.08.00.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%2.00.022.08.3%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%16.08.00.066.7%

Fundamentals of Compumedics

About Compumedics Ltd

Compumedics Limited engages in the research, development, manufacturing, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Okti; Grael PSG; Grael DC; Falcon HST; Somté, an investigative tool; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, the company provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and HD Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, summit IP, TCM5 FLEX transcutaneous monitors, and persyst software products. Further, it provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited operates as a subsidiary of D & DJ Burton Holdings Pty Ltd.

Fundamental data was last updated by Penke on 2024-04-13 09:53:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Compumedics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Compumedics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Compumedics to the Medical Devices industry mean.
  • A Net Profit Margin of -14.4% means that $-0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Compumedics Ltd:

  • The MRQ is -14.4%. The company is making a huge loss. -2
  • The TTM is -14.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.4%TTM-14.4%0.0%
TTM-14.4%YOY3.6%-18.0%
TTM-14.4%5Y-3.0%-11.4%
5Y-3.0%10Y1.4%-4.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.4%-11.2%-3.2%
TTM-14.4%-19.6%+5.2%
YOY3.6%-14.4%+18.0%
5Y-3.0%-21.3%+18.3%
10Y1.4%-24.8%+26.2%
1.1.2. Return on Assets

Shows how efficient Compumedics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Compumedics to the Medical Devices industry mean.
  • -14.9% Return on Assets means that Compumedics generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Compumedics Ltd:

  • The MRQ is -14.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.9%TTM-14.9%0.0%
TTM-14.9%YOY3.3%-18.1%
TTM-14.9%5Y-3.0%-11.8%
5Y-3.0%10Y2.4%-5.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.9%-4.0%-10.9%
TTM-14.9%-4.5%-10.4%
YOY3.3%-4.8%+8.1%
5Y-3.0%-4.0%+1.0%
10Y2.4%-5.2%+7.6%
1.1.3. Return on Equity

Shows how efficient Compumedics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Compumedics to the Medical Devices industry mean.
  • -33.5% Return on Equity means Compumedics generated $-0.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Compumedics Ltd:

  • The MRQ is -33.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.5%TTM-33.5%0.0%
TTM-33.5%YOY5.8%-39.2%
TTM-33.5%5Y-7.1%-26.4%
5Y-7.1%10Y3.3%-10.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.5%-3.9%-29.6%
TTM-33.5%-5.6%-27.9%
YOY5.8%-5.9%+11.7%
5Y-7.1%-6.1%-1.0%
10Y3.3%-7.1%+10.4%

1.2. Operating Efficiency of Compumedics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Compumedics is operating .

  • Measures how much profit Compumedics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Compumedics to the Medical Devices industry mean.
  • An Operating Margin of -8.3% means the company generated $-0.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Compumedics Ltd:

  • The MRQ is -8.3%. The company is operating very inefficient. -2
  • The TTM is -8.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-8.3%0.0%
TTM-8.3%YOY0.4%-8.7%
TTM-8.3%5Y0.8%-9.1%
5Y0.8%10Y4.0%-3.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.3%-22.8%+14.5%
TTM-8.3%-17.1%+8.8%
YOY0.4%-13.4%+13.8%
5Y0.8%-19.2%+20.0%
10Y4.0%-24.0%+28.0%
1.2.2. Operating Ratio

Measures how efficient Compumedics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are $1.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Compumedics Ltd:

  • The MRQ is 1.083. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.083. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.083TTM1.0830.000
TTM1.083YOY0.996+0.087
TTM1.0835Y0.999+0.085
5Y0.99910Y1.003-0.004
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0831.428-0.345
TTM1.0831.426-0.343
YOY0.9961.503-0.507
5Y0.9991.440-0.441
10Y1.0031.371-0.368

1.3. Liquidity of Compumedics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Compumedics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.39 means the company has $1.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Compumedics Ltd:

  • The MRQ is 1.393. The company is just able to pay all its short-term debts.
  • The TTM is 1.393. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.393TTM1.3930.000
TTM1.393YOY1.913-0.519
TTM1.3935Y2.134-0.741
5Y2.13410Y2.148-0.014
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3932.787-1.394
TTM1.3932.763-1.370
YOY1.9133.488-1.575
5Y2.1343.617-1.483
10Y2.1483.514-1.366
1.3.2. Quick Ratio

Measures if Compumedics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Compumedics to the Medical Devices industry mean.
  • A Quick Ratio of 0.89 means the company can pay off $0.89 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Compumedics Ltd:

  • The MRQ is 0.889. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.889. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.889TTM0.8890.000
TTM0.889YOY1.359-0.470
TTM0.8895Y1.466-0.577
5Y1.46610Y1.486-0.020
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8891.539-0.650
TTM0.8891.660-0.771
YOY1.3592.139-0.780
5Y1.4662.300-0.834
10Y1.4862.255-0.769

1.4. Solvency of Compumedics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Compumedics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Compumedics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.56 means that Compumedics assets are financed with 55.6% credit (debt) and the remaining percentage (100% - 55.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Compumedics Ltd:

  • The MRQ is 0.556. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.556. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.556TTM0.5560.000
TTM0.556YOY0.434+0.121
TTM0.5565Y0.419+0.137
5Y0.41910Y0.4190.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5560.389+0.167
TTM0.5560.386+0.170
YOY0.4340.338+0.096
5Y0.4190.442-0.023
10Y0.4190.460-0.041
1.4.2. Debt to Equity Ratio

Measures if Compumedics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Compumedics to the Medical Devices industry mean.
  • A Debt to Equity ratio of 125.1% means that company has $1.25 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Compumedics Ltd:

  • The MRQ is 1.251. The company is able to pay all its debts with equity. +1
  • The TTM is 1.251. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.251TTM1.2510.000
TTM1.251YOY0.768+0.483
TTM1.2515Y0.761+0.491
5Y0.76110Y0.760+0.001
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2510.559+0.692
TTM1.2510.560+0.691
YOY0.7680.478+0.290
5Y0.7610.624+0.137
10Y0.7600.674+0.086

2. Market Valuation of Compumedics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Compumedics generates.

  • Above 15 is considered overpriced but always compare Compumedics to the Medical Devices industry mean.
  • A PE ratio of -5.21 means the investor is paying $-5.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Compumedics Ltd:

  • The EOD is -7.669. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.209. Based on the earnings, the company is expensive. -2
  • The TTM is -5.209. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.669MRQ-5.209-2.460
MRQ-5.209TTM-5.2090.000
TTM-5.209YOY20.236-25.445
TTM-5.2095Y19.893-25.101
5Y19.89310Y29.297-9.404
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-7.669-1.037-6.632
MRQ-5.209-1.578-3.631
TTM-5.209-2.041-3.168
YOY20.236-2.971+23.207
5Y19.893-2.058+21.951
10Y29.297-1.463+30.760
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Compumedics Ltd:

  • The EOD is -10.770. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.316. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.316. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.770MRQ-7.316-3.455
MRQ-7.316TTM-7.3160.000
TTM-7.316YOY90.928-98.244
TTM-7.3165Y-5.915-1.401
5Y-5.91510Y-204.926+199.011
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-10.770-1.007-9.763
MRQ-7.316-1.544-5.772
TTM-7.316-3.018-4.298
YOY90.928-6.339+97.267
5Y-5.915-4.928-0.987
10Y-204.926-4.950-199.976
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Compumedics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.74 means the investor is paying $1.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Compumedics Ltd:

  • The EOD is 2.567. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.743. Based on the equity, the company is underpriced. +1
  • The TTM is 1.743. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.567MRQ1.743+0.823
MRQ1.743TTM1.7430.000
TTM1.743YOY1.164+0.579
TTM1.7435Y2.679-0.936
5Y2.67910Y3.469-0.790
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.5671.987+0.580
MRQ1.7432.379-0.636
TTM1.7432.444-0.701
YOY1.1643.215-2.051
5Y2.6793.833-1.154
10Y3.4694.163-0.694
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Compumedics Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Compumedics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.030-0.0300%0.008-469%-0.005-82%0.006-633%
Book Value Per Share--0.1030.1030%0.133-22%0.128-19%0.108-4%
Current Ratio--1.3931.3930%1.913-27%2.134-35%2.148-35%
Debt To Asset Ratio--0.5560.5560%0.434+28%0.419+33%0.419+33%
Debt To Equity Ratio--1.2511.2510%0.768+63%0.761+64%0.760+65%
Dividend Per Share----0%-0%-0%-0%
Eps---0.035-0.0350%0.008-551%-0.006-82%0.003-1416%
Free Cash Flow Per Share---0.025-0.0250%0.002-1543%-0.003-90%-0.001-94%
Free Cash Flow To Equity Per Share---0.030-0.0300%0.011-380%-0.001-95%0.001-3259%
Gross Profit Margin--3.1643.1640%-5.988+289%-1.737+155%-2.351+174%
Intrinsic Value_10Y_max---0.060--------
Intrinsic Value_10Y_min---0.303--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.014--------
Intrinsic Value_3Y_max---0.010--------
Intrinsic Value_3Y_min---0.056--------
Intrinsic Value_5Y_max---0.021--------
Intrinsic Value_5Y_min---0.114--------
Market Cap46948197.120+32%31889341.44031889341.4400%27460266.240+16%62184215.808-49%65904638.976-52%
Net Profit Margin---0.144-0.1440%0.036-502%-0.030-79%0.014-1135%
Operating Margin---0.083-0.0830%0.004-2397%0.008-1185%0.040-309%
Operating Ratio--1.0831.0830%0.996+9%0.999+8%1.003+8%
Pb Ratio2.567+32%1.7431.7430%1.164+50%2.679-35%3.469-50%
Pe Ratio-7.669-47%-5.209-5.2090%20.236-126%19.893-126%29.297-118%
Price Per Share0.265+32%0.1800.1800%0.155+16%0.351-49%0.372-52%
Price To Free Cash Flow Ratio-10.770-47%-7.316-7.3160%90.928-108%-5.915-19%-204.926+2701%
Price To Total Gains Ratio-8.858-47%-6.017-6.0170%19.123-131%43.928-114%34.550-117%
Quick Ratio--0.8890.8890%1.359-35%1.466-39%1.486-40%
Return On Assets---0.149-0.1490%0.033-557%-0.030-80%0.024-729%
Return On Equity---0.335-0.3350%0.058-682%-0.071-79%0.033-1116%
Total Gains Per Share---0.030-0.0300%0.008-469%-0.005-82%0.006-633%
Usd Book Value--11748309.30011748309.3000%15152499.300-22%14534992.208-19%12292658.614-4%
Usd Book Value Change Per Share---0.019-0.0190%0.005-469%-0.004-82%0.004-633%
Usd Book Value Per Share--0.0660.0660%0.086-22%0.082-19%0.069-4%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.022-0.0220%0.005-551%-0.004-82%0.002-1416%
Usd Free Cash Flow---2799786.342-2799786.3420%193974.600-1543%-293788.148-90%-165585.004-94%
Usd Free Cash Flow Per Share---0.016-0.0160%0.001-1543%-0.002-90%-0.001-94%
Usd Free Cash Flow To Equity Per Share---0.019-0.0190%0.007-380%-0.001-95%0.001-3259%
Usd Market Cap30154827.010+32%20482524.00720482524.0070%17637729.006+16%39940921.813-49%42330549.614-52%
Usd Price Per Share0.170+32%0.1160.1160%0.100+16%0.225-49%0.239-52%
Usd Profit---3932160.600-3932160.6000%871601.100-551%-721559.820-82%296999.520-1424%
Usd Revenue--27238658.40027238658.4000%24250678.800+12%24725723.880+10%23379976.920+17%
Usd Total Gains Per Share---0.019-0.0190%0.005-469%-0.004-82%0.004-633%
 EOD+5 -3MRQTTM+0 -0YOY+7 -275Y+6 -2810Y+5 -29

4.2. Fundamental Score

Let's check the fundamental score of Compumedics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.669
Price to Book Ratio (EOD)Between0-12.567
Net Profit Margin (MRQ)Greater than0-0.144
Operating Margin (MRQ)Greater than0-0.083
Quick Ratio (MRQ)Greater than10.889
Current Ratio (MRQ)Greater than11.393
Debt to Asset Ratio (MRQ)Less than10.556
Debt to Equity Ratio (MRQ)Less than11.251
Return on Equity (MRQ)Greater than0.15-0.335
Return on Assets (MRQ)Greater than0.05-0.149
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Compumedics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.290
Ma 20Greater thanMa 500.272
Ma 50Greater thanMa 1000.301
Ma 100Greater thanMa 2000.298
OpenGreater thanClose0.265
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Net Debt  -3,0051,392-1,613663-950204-7466,4155,669
EBITDA  5,884-4,9769089471,855-5061,349-3,870-2,521



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets41,182
Total Liabilities22,891
Total Stockholder Equity18,291
 As reported
Total Liabilities 22,891
Total Stockholder Equity+ 18,291
Total Assets = 41,182

Assets

Total Assets41,182
Total Current Assets29,519
Long-term Assets11,663
Total Current Assets
Cash And Cash Equivalents 3,797
Net Receivables 15,032
Inventory 10,690
Total Current Assets  (as reported)29,519
Total Current Assets  (calculated)29,519
+/-0
Long-term Assets
Property Plant Equipment 3,618
Long Term Investments 703
Intangible Assets 6,242
Other Assets 1,100
Long-term Assets  (as reported)11,663
Long-term Assets  (calculated)11,663
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities21,188
Long-term Liabilities1,703
Total Stockholder Equity18,291
Total Current Liabilities
Short-term Debt 7,906
Short Long Term Debt 7,225
Accounts payable 5,256
Other Current Liabilities 5,333
Total Current Liabilities  (as reported)21,188
Total Current Liabilities  (calculated)25,720
+/- 4,532
Long-term Liabilities
Long term Debt Total 1,560
Capital Lease Obligations Min Short Term Debt-5,870
Deferred Long Term Liability 6,242
Long-term Liabilities  (as reported)1,703
Long-term Liabilities  (calculated)1,932
+/- 229
Total Stockholder Equity
Common Stock35,654
Retained Earnings -17,791
Accumulated Other Comprehensive Income 428
Total Stockholder Equity (as reported)18,291
Total Stockholder Equity (calculated)18,291
+/-0
Other
Capital Stock35,654
Cash and Short Term Investments 3,797
Common Stock Shares Outstanding 177,163
Current Deferred Revenue2,693
Liabilities and Stockholders Equity 41,182
Net Debt 5,669
Net Invested Capital 25,721
Net Tangible Assets 18,291
Net Working Capital 8,331
Property Plant and Equipment Gross 3,618
Short Long Term Debt Total 9,466



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-30
> Total Assets 
0
0
34,459
39,197
43,624
23,762
24,509
24,549
22,175
19,251
20,142
21,458
21,811
23,104
19,875
19,087
19,522
21,675
26,123
29,228
34,652
38,661
35,527
38,546
41,709
41,182
41,18241,70938,54635,52738,66134,65229,22826,12321,67519,52219,08719,87523,10421,81121,45820,14219,25122,17524,54924,50923,76243,62439,19734,45900
   > Total Current Assets 
0
0
22,732
26,100
25,223
22,586
23,141
21,549
21,257
17,818
17,421
17,028
16,526
17,127
15,228
14,895
15,948
18,208
22,366
25,291
29,800
30,214
28,886
31,934
33,547
29,519
29,51933,54731,93428,88630,21429,80025,29122,36618,20815,94814,89515,22817,12716,52617,02817,42117,81821,25721,54923,14122,58625,22326,10022,73200
       Cash And Cash Equivalents 
0
0
13,107
11,447
8,533
5,366
6,352
3,922
3,319
363
571
2,607
1,836
1,153
1,099
1,292
1,054
2,230
3,066
4,102
3,906
4,598
6,412
6,770
7,294
3,797
3,7977,2946,7706,4124,5983,9064,1023,0662,2301,0541,2921,0991,1531,8362,6075713633,3193,9226,3525,3668,53311,44713,10700
       Net Receivables 
0
0
6,938
8,993
7,983
8,624
10,239
11,239
12,945
12,464
12,166
10,623
9,708
10,241
8,840
7,436
8,322
10,259
12,790
13,771
18,333
15,980
13,643
15,485
16,544
15,032
15,03216,54415,48513,64315,98018,33313,77112,79010,2598,3227,4368,84010,2419,70810,62312,16612,46412,94511,23910,2398,6247,9838,9936,93800
       Other Current Assets 
0
0
153
696
187
180
69
426
167
0
0
0
0
0
0
669
427
501
856
654
1,882
1,837
1,047
2,474
2,419
2,500
2,5002,4192,4741,0471,8371,8826548565014276690000001674266918018769615300
   > Long-term Assets 
0
0
11,727
13,097
18,401
1,176
1,368
3,000
918
1,433
2,721
4,430
5,285
5,977
4,647
4,192
3,574
3,467
3,757
3,937
4,852
8,447
6,641
6,612
8,162
11,663
11,6638,1626,6126,6418,4474,8523,9373,7573,4673,5744,1924,6475,9775,2854,4302,7211,4339183,0001,3681,17618,40113,09711,72700
       Property Plant Equipment 
0
0
4,193
822
7,019
1,176
1,368
1,521
918
613
2,721
4,430
5,097
5,049
4,647
4,192
672
797
832
718
666
1,652
3,083
1,711
1,213
3,618
3,6181,2131,7113,0831,6526667188327976724,1924,6475,0495,0974,4302,7216139181,5211,3681,1767,0198224,19300
       Goodwill 
0
0
0
0
473
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000004730000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
703
7030000000000000000000000000
       Intangible Assets 
0
0
7,332
11,951
10,804
0
0
1,361
0
820
2,028
3,559
4,178
4,234
3,892
3,454
2,902
2,670
2,410
2,446
4,042
6,795
2,777
4,080
6,449
6,242
6,2426,4494,0802,7776,7954,0422,4462,4102,6702,9023,4543,8924,2344,1783,5592,02882001,3610010,80411,9517,33200
       Other Assets 
0
0
202
324
6,167
0
0
119
0
820
2,028
3,559
4,365
5,161
3,892
3,454
2,902
2,670
515
3,219
4,186
6,795
3,558
0
0
1,100
1,100003,5586,7954,1863,2195152,6702,9023,4543,8925,1614,3653,5592,0288200119006,16732420200
> Total Liabilities 
0
0
4,392
7,034
13,398
12,087
10,564
15,202
15,458
12,337
11,635
9,979
9,615
10,349
10,660
10,734
10,360
10,407
11,527
9,177
11,492
11,344
13,733
16,391
18,118
22,891
22,89118,11816,39113,73311,34411,4929,17711,52710,40710,36010,73410,66010,3499,6159,97911,63512,33715,45815,20210,56412,08713,3987,0344,39200
   > Total Current Liabilities 
0
0
2,836
4,810
9,804
11,422
8,229
10,531
12,151
12,318
11,414
9,792
8,566
10,219
10,407
10,581
10,244
10,207
11,168
8,944
11,291
10,194
12,436
15,354
17,540
21,188
21,18817,54015,35412,43610,19411,2918,94411,16810,20710,24410,58110,40710,2198,5669,79211,41412,31812,15110,5318,22911,4229,8044,8102,83600
       Short-term Debt 
0
0
0
0
0
4,729
1,932
1,425
3,196
3,396
2,745
2,484
1,064
2,754
1,989
2,339
2,018
2,002
2,566
707
1,853
1,570
3,953
5,071
6,169
7,906
7,9066,1695,0713,9531,5701,8537072,5662,0022,0182,3391,9892,7541,0642,4842,7453,3963,1961,4251,9324,72900000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,018
2,002
2,559
704
1,840
1,558
3,051
4,408
5,802
7,225
7,2255,8024,4083,0511,5581,8407042,5592,0022,0180000000000000000
       Accounts payable 
0
0
0
2,647
2,155
0
2,677
3,871
5,225
4,892
4,396
3,144
3,465
3,133
3,468
3,248
3,353
2,928
3,016
2,945
3,910
4,386
2,926
4,449
4,738
5,256
5,2564,7384,4492,9264,3863,9102,9453,0162,9283,3533,2483,4683,1333,4653,1444,3964,8925,2253,8712,67702,1552,647000
       Other Current Liabilities 
0
0
606
1,879
7,321
1,929
2,338
4,192
2,615
2,971
3,298
3,141
3,080
3,542
3,658
3,673
3,597
3,889
3,917
3,924
3,957
2,862
3,840
4,085
4,710
5,333
5,3334,7104,0853,8402,8623,9573,9243,9173,8893,5973,6733,6583,5423,0803,1413,2982,9712,6154,1922,3381,9297,3211,87960600
   > Long-term Liabilities 
0
0
1,556
2,225
3,594
665
2,335
4,671
3,307
19
221
187
1,049
130
253
153
116
200
359
233
201
1,150
1,297
1,037
578
1,703
1,7035781,0371,2971,1502012333592001161532531301,049187221193,3074,6712,3356653,5942,2251,55600
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
8
38
23
846
749
379
1,560
1,5603797498462338811000000000000000000
       Other Liabilities 
0
0
1,943
75
129
158
213
125
60
12
205
170
167
130
160
153
116
200
348
225
163
1,127
451
288
199
143
1431992884511,1271632253482001161531601301671702051260125213158129751,94300
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,902
2,670
2,410
2,446
4,042
6,795
2,777
4,080
6,449
6,242
6,2426,4494,0802,7776,7954,0422,4462,4102,6702,9020000000000000000
> Total Stockholder Equity
0
0
30,067
32,163
30,226
11,675
13,945
9,347
6,717
6,914
8,507
11,479
12,196
12,755
9,215
8,353
9,162
11,268
14,596
20,051
23,160
27,317
21,794
22,155
23,591
18,291
18,29123,59122,15521,79427,31723,16020,05114,59611,2689,1628,3539,21512,75512,19611,4798,5076,9146,7179,34713,94511,67530,22632,16330,06700
   Common Stock
0
0
22,970
29,181
29,147
29,147
29,020
29,020
29,020
29,220
30,752
31,007
31,019
31,019
31,019
31,269
31,269
31,269
31,419
35,654
35,654
35,654
35,654
35,654
35,654
35,654
35,65435,65435,65435,65435,65435,65435,65431,41931,26931,26931,26931,01931,01931,01931,00730,75229,22029,02029,02029,02029,14729,14729,18122,97000
   Retained Earnings Total Equity00000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-936
-1,337
-1,846
-2,279
-2,656
-385
-783
-1,206
-1,216
-739
-261
-972
-595
-695
-559
-654
-739
-414
-258
164
-473
-394
428
428-394-473164-258-414-739-654-559-695-595-972-261-739-1,216-1,206-783-385-2,656-2,279-1,846-1,337-936000
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
0
6,083
936
1,331
0
0
0
0
0
0
0
0
0
0
0
-695
-559
-655
-739
-414
13
-21,630
-22,628
-23,985
-17,863
-17,863-23,985-22,628-21,63013-414-739-655-559-695000000000001,3319366,08300



Balance Sheet

Currency in AUD. All numbers in thousands.